FDAnews Device Daily Bulletin

Bone Index Receives FDA Clearance for the Second Generation Bindex

Jan. 23, 2017

Finland–based, Bone Index has gained FDA marketing clearance for its second generation Bindex device to help in osteoporosis diagnosis.

The device measures the cortical bone thickness of the tibia and the algorithm calculates the density index. — Cynthia Jessup

View today's stories